Tuesday, May 15, 2018

TherOx Finds Debt Funding

Irvine-based medical device company TherOx, which is developing medical devices to treat acute myocardial infarction (AMI), recently announced it has received a debt financing. The financing came from its existing investors, ZOLL Medical Corporation, which is owned by Asahi Kasei Group. According to ThereOx, the proceeds of the funding will go towards the U.S. market introduction and commercialization of its SuperSaturated Oxygen (SSO2) Therapy system upon receipt of Food and Drug Administration (FDA) premarket approval.